I listened to this live a couple of days ago. It is really worth a viewing.
"In this webinar we talked about the latest updates on chronic myeloid leukaemia (CML) and looked at the results of different research projects provided by the American Society of Hematology (ASH). We also explored new treatment drugs available to treat COVID-19 as well as discussing new treatment studies and what this could mean for CML patients."